Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1975 Aug;72(8):3190–3193. doi: 10.1073/pnas.72.8.3190

Mutagenicity of chloroacetaldehyde, a possible metabolic product of 1,2-dichloroethane (ethylene dichloride), chloroethanol (ethylene chlorohydrin), vinyl chloride, and cyclophosphamide.

J McCann, V Simmon, D Streitwieser, B N Ames
PMCID: PMC432947  PMID: 1059105

Abstract

We have previously described a very sensitive and efficient bacterial test designed to detect chemical carcinogens as mutagens. Chloroacetaldehyde is mutagenic in this system and is of interest because it is a possible metabolite in mammals of the large volume industrial chemicals 1,2-dichloroethane (ethylene dichloride) (3.5 billion kg/yr, U.S.) and vinyl chloride (2.5 billion kg/yr, U.S.), and of the antineoplastic agent cyclophosphamide. Chloroacetaldehyde reverts a new Salmonella bacterial tester strain (TA100). Chloroacetaldehyde is shown to be hundreds of times more effective in reversion of TA100 than is chloroethanol (ethylene chlorohydrin), a known metabolic precursor of chloroacetaldehyde and a possible metabolite of dichloroethane and vinyl chloride, or than vinyl chloride, which is itself mutagenic for TA100. Chloroethanol is shown to be activated by rat (or human) liver homogenates to a more highly mutagenic form with reversion properties similar to chloroacetaldehyde. Reversion properties of cyclophosphamide after in vitro metabolic activation suggest that chloroacetaldehyde is not the active mutagenic form of this antineoplastic drug.

Full text

PDF
3190

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMBROSE A. M. Toxicological studies of compounds investigated for use as inhibitors of biological processes. II. Toxicity of ethylene chlorohydrin. AMA Arch Ind Hyg Occup Med. 1950 Nov;2(5):591–597. [PubMed] [Google Scholar]
  2. Ames B. N., Durston W. E., Yamasaki E., Lee F. D. Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc Natl Acad Sci U S A. 1973 Aug;70(8):2281–2285. doi: 10.1073/pnas.70.8.2281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ames B. N., Gurney E. G., Miller J. A., Bartsch H. Carcinogens as frameshift mutagens: metabolites and derivatives of 2-acetylaminofluorene and other aromatic amine carcinogens. Proc Natl Acad Sci U S A. 1972 Nov;69(11):3128–3132. doi: 10.1073/pnas.69.11.3128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ames B. N., Kammen H. O., Yamasaki E. Hair dyes are mutagenic: identification of a variety of mutagenic ingredients. Proc Natl Acad Sci U S A. 1975 Jun;72(6):2423–2427. doi: 10.1073/pnas.72.6.2423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ames B. N., Lee F. D., Durston W. E. An improved bacterial test system for the detection and classification of mutagens and carcinogens. Proc Natl Acad Sci U S A. 1973 Mar;70(3):782–786. doi: 10.1073/pnas.70.3.782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ames B. N., Sims P., Grover P. L. Epoxides of carcinogenic polycyclic hydrocarbons are frameshift mutagens. Science. 1972 Apr 7;176(4030):47–49. doi: 10.1126/science.176.4030.47. [DOI] [PubMed] [Google Scholar]
  7. Ames B. N., Whitfield H. J., Jr Frameshift mutagenesis in Salmonella. Cold Spring Harb Symp Quant Biol. 1966;31:221–225. doi: 10.1101/sqb.1966.031.01.030. [DOI] [PubMed] [Google Scholar]
  8. Barrio J. R., Secrist J. A., 3rd, Leonard N. J. Fluorescent adenosine and cytidine derivatives. Biochem Biophys Res Commun. 1972 Jan 31;46(2):597–604. doi: 10.1016/s0006-291x(72)80181-5. [DOI] [PubMed] [Google Scholar]
  9. Bartsch H., Malaveille C., Montesano R. Human, rat and mouse liver-mediated mutagenicity of vinyl chloride in S. typhimurium strains. Int J Cancer. 1975 Mar 15;15(3):429–437. doi: 10.1002/ijc.2910150309. [DOI] [PubMed] [Google Scholar]
  10. Blair A. H., Vallee B. L. Some catalytic properties of human liver alcohol dehydrogenase. Biochemistry. 1966 Jun;5(6):2026–2034. doi: 10.1021/bi00870a034. [DOI] [PubMed] [Google Scholar]
  11. Brem H., Stein A. B., Rosenkranz H. S. The mutagenicity and DNA-modifying effect of haloalkanes. Cancer Res. 1974 Oct;34(10):2576–2579. [PubMed] [Google Scholar]
  12. Carter E. A., Isselbacher K. J. Hepatic microsomal ethanol oxidation. Mechanism and physiologic significance. Lab Invest. 1972 Sep;27(3):283–286. [PubMed] [Google Scholar]
  13. Creech H. J., Preston R. K., Peck R. M., O'Connell A. P. Antitumor and mutagenic properties of a variety of heterocyclic nitrogen and sulfur mustards. J Med Chem. 1972 Jul;15(7):739–746. doi: 10.1021/jm00277a011. [DOI] [PubMed] [Google Scholar]
  14. Creech J. L., Jr, Johnson M. N. Angiosarcoma of liver in the manufacture of polyvinyl chloride. J Occup Med. 1974 Mar;16(3):150–151. [PubMed] [Google Scholar]
  15. Ducatman A., Hirschhorn K., Selikoff I. J. Vinyl chloride exposure and human chromosome aberrations. Mutat Res. 1975 Jun;31(3):163–168. doi: 10.1016/0165-1161(75)90085-0. [DOI] [PubMed] [Google Scholar]
  16. Durston W. E., Ames B. N. A simple method for the detection of mutagens in urine: studies with the carcinogen 2-acetylaminofluorene. Proc Natl Acad Sci U S A. 1974 Mar;71(3):737–741. doi: 10.1073/pnas.71.3.737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ellenberger J., Mohn G. Mutagenic activity of cyclophosphamide, ifosfamide, and trofosfamide in different genes of escherichia coli and salmonella typhimurium after biotransformation through extracts of rodent liver. Arch Toxicol. 1975;33(3):225–240. doi: 10.1007/BF00311275. [DOI] [PubMed] [Google Scholar]
  18. Funes-Cravioto F., Lambert B., Lindsten J., Ehrenberg L., Natarajan A. T., Osterman-Golkar S. Letter: chromosome aberrations in workers exposed to vinyl chloride. Lancet. 1975 Feb 22;1(7904):459–459. doi: 10.1016/s0140-6736(75)91534-2. [DOI] [PubMed] [Google Scholar]
  19. Jones A. R. The metabolism of biological alkylating agents. Drug Metab Rev. 1973;2(1):71–100. doi: 10.3109/03602537409030006. [DOI] [PubMed] [Google Scholar]
  20. Kier L. D., Yamasaki E., Ames B. N. Detection of mutagenic activity in cigarette smoke condensates. Proc Natl Acad Sci U S A. 1974 Oct;71(10):4159–4163. doi: 10.1073/pnas.71.10.4159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lawrence W. H., Dillingham E. O., Turner J. E., Autian J. Toxicity profile of chloroacetaldehyde. J Pharm Sci. 1972 Jan;61(1):19–25. doi: 10.1002/jps.2600610103. [DOI] [PubMed] [Google Scholar]
  22. Lee C. H., Wetmur J. G. Physical studies of chloroacetaldehyde labelled fluorescent DNA. Biochem Biophys Res Commun. 1973 Feb 5;50(3):879–885. doi: 10.1016/0006-291x(73)91327-2. [DOI] [PubMed] [Google Scholar]
  23. Malaveille C., Bartsch H., Barbin A., Camus A. M., Montesano R., Croisy A., Jacquignon P. Mutagenicity of vinyl chloride, chloroethyleneoxide, chloroacetaldehyde and chloroethanol. Biochem Biophys Res Commun. 1975 Mar 17;63(2):363–370. doi: 10.1016/0006-291x(75)90697-x. [DOI] [PubMed] [Google Scholar]
  24. McCann J., Spingarn N. E., Kobori J., Ames B. N. Detection of carcinogens as mutagens: bacterial tester strains with R factor plasmids. Proc Natl Acad Sci U S A. 1975 Mar;72(3):979–983. doi: 10.1073/pnas.72.3.979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. McConnell G., Ferguson D. M., Pearson C. R. Chlorinated hydrocarbons and the environment. Endeavour. 1975 Jan;34(121):13–18. doi: 10.1016/0160-9327(75)90062-9. [DOI] [PubMed] [Google Scholar]
  26. Olson W. A., Habermann R. T., Weisburger E. K., Ward J. M., Weisburger J. H. Induction of stomach cancer in rats and mice by halogenated aliphatic fumigants. J Natl Cancer Inst. 1973 Dec;51(6):1993–1995. doi: 10.1093/jnci/51.6.1993. [DOI] [PubMed] [Google Scholar]
  27. Rosenkranz S., Carr H. S., Rosenkranz H. S. 2-Haloethanols: mutagenicity and reactivity with DNA. Mutat Res. 1974 Oct;26(5):367–370. doi: 10.1016/s0027-5107(74)80002-3. [DOI] [PubMed] [Google Scholar]
  28. Siebert D. A new method for testing genetically active metabolites. Urinary assay with cyclophosphamide (endoxan, cytoxan) and Saccharomyces cerevisiae. Mutat Res. 1973 Mar;17(3):307–314. doi: 10.1016/0027-5107(73)90002-x. [DOI] [PubMed] [Google Scholar]
  29. Siebert D., Simon U. Cyclophosphamide: pilot study of genetically active metabolites in the urine of a treated human patient. Induction of mitotic gene conversions in yeast. Mutat Res. 1973 Jul;19(1):65–72. doi: 10.1016/0027-5107(73)90114-0. [DOI] [PubMed] [Google Scholar]
  30. Van Duuren B. L. On the possible mechanism of carcinogenic action of vinyl chloride. Ann N Y Acad Sci. 1975 Jan 31;246:258–267. doi: 10.1111/j.1749-6632.1975.tb51101.x. [DOI] [PubMed] [Google Scholar]
  31. Vatsis K. P., Kowalchyk J. A., Schulman M. P. Ethanol and drug metabolism in mouse liver microsomes subsequent to lipid peroxidation-induced destruction of cytochrome P-450. Biochem Biophys Res Commun. 1974 Nov 6;61(1):258–264. doi: 10.1016/0006-291x(74)90561-0. [DOI] [PubMed] [Google Scholar]
  32. Viola P. L., Bigotti A., Caputo A. Oncogenic response of rat skin, lungs, and bones to vinyl chloride. Cancer Res. 1971 May;31(5):516–522. [PubMed] [Google Scholar]
  33. Voogd C. E., Jacobs J. J., van der Stel J. J. On the mutagenic action of dichlorvos. Mutat Res. 1972 Dec;16(4):413–416. doi: 10.1016/0027-5107(72)90210-2. [DOI] [PubMed] [Google Scholar]
  34. Voogd C. E., Vet P vd Mutagenic action of ethylene halogenhydrins. Experientia. 1969 Jan 15;25(1):85–86. doi: 10.1007/BF01903914. [DOI] [PubMed] [Google Scholar]
  35. Yllner S. Metabolism of 1,2-dichloroethane- 14 C in the mouse. Acta Pharmacol Toxicol (Copenh) 1971;30(3):257–265. doi: 10.1111/j.1600-0773.1971.tb00657.x. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES